Loading...
Loading...
NuPathe
PATH fell 33.41% to $2.89 at 9:55 am. NuPathe has entered into agreements with existing and new investors for the sale of $28 million of securities.
Blyth
BTH shares dipped 18.94% to $26.40. Blyth's ViSalus subsidiary withdrew its initial public offering.
OMNOVA Solutions
OMN dipped 17.60% to $7.21. OMNOVA Solutions reported a surge in its net income for the third quarter. However, its net sales for the period dropped 8.5% to $288.2 million.
Catalyst Pharmaceutical Partners
CPRX dropped 14.13% to $1.58. Catalyst Pharma updated guidance on timing of top-line data from CPP-109 Phase IIB clinical trial.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in